Back to Results
First PageMeta Content
Autoimmune diseases / Connective tissue diseases / Rituximab / Lymphocytic leukemia / Arthritis / Dermatomyositis / B-cell chronic lymphocytic leukemia / Inclusion body myositis / Juvenile dermatomyositis / Health / Medicine / Anatomy


ARTHRITIS & RHEUMATISM Vol. 65, No. 2, February 2013, pp 314–324 DOI[removed]art.37754 © 2013, American College of Rheumatology Rituximab in the Treatment of Refractory
Add to Reading List

Document Date: 2013-02-15 16:49:23

Open Document

File Size: 212,44 KB

Share Result on Facebook

City

Washington DC / Oxford / Pittsburgh / Bethesda / Rochester / Baltimore / Kansas City / Nashville / /

Company

Novartis / Voskuyl AE / Genentech / Clinical Studies Group / Chiu YE Co / International Myositis Assessment / IgG / AEs / LG / Genzyme / MedImmune / Becton Dickinson / Pearson / CBC / Grifols / Pilkington / /

Country

Canada / Lebanon / /

Currency

USD / /

/

Event

Product Issues / Person Communication and Meetings / /

Facility

University of Texas Health Science Center / University of Kansas Medical Center / Washington DC VA Medical Center / American College of Rheumatology Rituximab / University of Michigan / National Institute of Arthritis / National Institute of Allergy / University of Miami / University of Pittsburgh / DartmouthHitchcock Medical Center / National Institute of Environmental Health Sciences / University of California at Los Angeles / Vanderbilt University Medical Center / National Cancer Institute / Mayo Clinic / Biomedical Science Tower / University of Pitts / University of Pittsburgh School / University of Toronto / /

IndustryTerm

study protocol / treatment of many autoimmune diseases / organ systems / printing differences / /

MedicalCondition

refractory disease / treatment-refractory disease / myositis disease / mean disease / infectious adverse events Adverse event Common / JE / another connective tissue disease / myopathy / herpes zoster / individual myositis / ARTHRITIS / Infectious complications / rheumatoid arthritis / cellulitis / connective tissue diseases / female IIM subset PM DM Juvenile DM Disease / noncorticosteroid immunosuppressive agents Myositis / septic arthritis / refractory dermatomyositis / chronic inflammation / progressive multifocal leukoencephalopathy / inclusion-body myositis / adult and juvenile idiopathic inflammatory myopathies / Grave’s disease / Juvenile Dermatomyositis / Club Rhumatismes et Inflammation / inflammatory myopathies / adverse events Headache Nausea/vomiting Diarrhea Rash Cough / idiopathic inflammatory myopathies / childhood myositis / adult and pediatric myositis / severe juvenile dermatomyositis / pneumonia / adult and juvenile myositis / demonstrable muscle weakness / inflammatory myopathy / cancer / vasculitis / respiratory failure / increased disease / stroke / myositis / polymyositis-dermatomyositis / juvenile rheumatoid arthritis / rash / Skin Diseases / hypercholesterolemia / inflammatory / individual myositis disease / overall disease / long disease / adult myositis / adult polymyositis / refractory inflammatory myopathies / chronic lymphocytic leukemia / autoimmune illness / urinary tract infection / refractory polymyositis / muscle weakness / extramuscular disease / chronic rheumatic diseases / syncope / adult and juvenile dermatomyositis / defined RITUXIMAB IN REFRACTORY ADULT AND JUVENILE MYOSITIS / RITUXIMAB IN REFRACTORY ADULT AND JUVENILE MYOSITIS / prospective myositis / MS / acquired disorders / Infections / dense hemiparesis / neurologic symptoms / muscle atrophy / autoimmune diseases / cold Pruritus Fatigue/malaise Leukopenia Nasal congestion Dizziness/vertigo Chills Sweats Hypertension Hypotension Bronchospasm Joint pain/swelling Flushing Hypogammaglobulinemia Hypersensitivity reactions Infectious / concomitant illness / dysrhythmia / venous thrombosis / Refractory myositis / disease / myositis trial assessing muscle weakness / concurrent/underlying illness / both adult and pediatric myositis / idiopathic inflammatory myopathy / adult disease / histoplasmosis / thyroiditis / undetermined myopathy / B cell lymphomas / heart failure / hypercalcemia / chronic diseases / prior central nervous system toxoplasmosis / recently validated myositis disease / connective tissue disease / ANCA-associated vasculitis / Dermatomyositis / predominantly proximal muscle weakness / polymyositis / /

MedicalTreatment

dietary supplements / retreatment / immunosuppressive therapy / /

MusicGroup

Nausea / /

Organization

Hospital for Sick Children / Institutional Review Board / General Clinical Research Center / University of Toronto / Toronto / University of Michigan / University of Texas Health Science Center at Houston / American College of Rheumatology Rituximab / Data and Safety Monitoring Board / University of Miami / Miami / National Institute of Allergy and Infectious Diseases / University of Pittsburgh School of Medicine / National Institute of Environmental Health Sciences / DartmouthHitchcock Medical Center / National Institute of Arthritis and Musculoskeletal / Vanderbilt University Medical Center / University of California at Los Angeles / National Cancer Institute / National Institute of Health / University of Kansas Medical Center / Food and Drug Administration / Arthritis Foundation / RIM Steering Committee / Epidemiology Data Center / Chester V / Adjudication Committee / Washington DC VA Medical Center / University of Pittsburgh / Pittsburgh / Division of Rheumatology and Clinical Immunology / Steering Committee / University of Pitts / /

Person

Rita Volochayev / M. Reed / Kathleen Coyle / Howard E. Rockette / Maureen Laffoon / M. Feldman / Christopher Bise / James Witter / Care Res (Hoboken) / Lisa Kruse / J. Barohn / Fernandez R. Rituximab / David Lacomis / Steven Belle / Joseph Shrader / Susana Serrate-Sztein / Leah Kramer / Rohit Aggarwal / Robert Wortmann / O. Harris-Love / Laura Herbelin / Hashimoto / Noreen Fertig / Stephanie S. Kelley / Mina Jain / Kelly Reckley / Mark Gourley / Frederick W. Miller / Jane Jaquith / Chester V. Oddis / Patience White / Sharon Lawlor / Diane C. Koontz / P. Ascherman / Daniel Furst / Marc C. Levesque / Chester V / /

Position

Prime Minister / adult PM / physician / physical therapist / AUTHOR / same investigator / clinical site investigator / RIM Study investigator / investigator / refractory adult PM / principal investigator / female IIM subset PM / Chair / juvenile PM / Rider / /

Product

cyclosporine / prednisone / azathioprine / leflunomide / cyclophosphamide / response / /

ProvinceOrState

Minnesota / Allegheny County / Michigan / California / Ontario / Kansas / Maryland / Pennsylvania / Florida / /

RadioStation

North Am 2002 / Reed AM / /

Technology

alpha / study protocol / antibodies / /

SocialTag